MPS VII, Mucopolysaccharidosis VII, Sly Syndrome
Conditions
Keywords
Expanded Access, Compassionate Use
Brief summary
Individual patient expanded access requests may be considered for patients who have no other treatment options
Detailed description
Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below.
Interventions
DRUGMepsevii
Sponsors
Ultragenyx Pharmaceutical Inc
Eligibility
Sex/Gender
ALL
Inclusion criteria
\-
Exclusion criteria
\-
Contacts
CONTACTEarly Access
Outcome results
None listed